nimodipine has been researched along with Diabetic Retinopathy in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riva, CE | 1 |
Falsini, B | 1 |
Anselmi, G | 1 |
Gari, M | 1 |
1 other study available for nimodipine and Diabetic Retinopathy
Article | Year |
---|---|
[Clinic use of Laser Doppler Flowmetry (LDF) in the study of subfoveal choroidal circulation].
Topics: Carbon Dioxide; Choroid; Diabetic Retinopathy; Fovea Centralis; Humans; Laser-Doppler Flowmetry; Low | 2011 |